1. Introduction
===============

The importance of psychosocial stress as a risk factor for a variety of negative health outcomes is widely recognized. Stress induces endocrine and immune system responses that help coping with the change in demand ([@bib16]) and stressors exert these influences by regulation of genes. Findings from previous gene expression studies in animal models show changes due to acute stress exposure cannot be readily translated to the human paradigm ([@bib10], [@bib15]). It has been suggested that peripheral blood mononuclear cell (PBMC) gene expression may provide an indicator of gene activation changes as a response to stress in humans ([@bib27]), as lymphocytes have been shown to be perturbed following acute psychological stress ([@bib1]), probably mediated through endocrine and immune markers that are activated by the stressor. Only very few studies have investigated gene expression alterations due to stress in humans. Studies examining genome-wide transcriptional activity in PBMCs have been reported. One examined chronic isolation and showed it was associated with specific signaling pathways involved in immune regulation and biological stress responses ([@bib6]). A more recent study associated chronic care-giving stress with alterations in glucocorticoid signal transduction as reflected by altered gene expression compared to a control group ([@bib17]). Microarrays, which allow high-throughput profiling of transcriptional activity, are powerful tools that detect signatures of biological processes that underlie adaptive and maladaptive responses to a challenge of the system. Measurement of expression of multiple genes or even genome-wide transcriptional activity patterns is warranted. Previous studies have not attempted to study gene expression alterations using more than one single measurement time point. However, considering the complex chronology of biological processes that occur due to exposure to an acute stressor, repeated measurement of gene expression is crucial. In the current pilot study, we attempted to repeatedly measure gene expression patterns using a genome-wide approach allowing us to examine biological pathways changes that follow an acute psychosocial laboratory stressor in adult healthy men. As this is a "proof of concept" approach that will drive future research endeavors using a repeated measurement approach, no hypotheses about alterations in specific pathways were formulated. Therefore, the following analyses should be regarded as explorative in nature and will hopefully inform future decisions on formulating specific hypotheses. However, we expected to find changes in processes that are relevant for the biological response to stress. In particular, psychological stress is known to activate the hypothalamic--pituitary--adrenal (HPA) axis ([@bib5]). The HPA axis plays a fundamental role in regulating other homeostatic systems, including the sympathetic nervous system and the immune system. Cortisol exerts inhibitory effects on the secretion of pro-inflammatory cytokines, including interleukin (IL)-6, and helps return these cytokines to baseline levels after stress. Increased sympathetic responses may mediate increased immune responses especially during stress. Thus, we expected changes in gene expression profiles that were closely related to changes in these biological stress systems.

2. Methods
==========

2.1. Participants and conditions
--------------------------------

This study was approved by the Institutional Review Boards of Emory University School of Medicine and the Centers for Disease Control and Prevention (CDC). All subjects were recruited via newspaper advertisement. Only male participants were included in the study. Exclusionary criteria were significant medical illness, past or current presence of psychotic symptoms or bipolar disorder, current presence of psychoactive substance abuse/dependency or eating disorders, as well as hormonal and psychotropic medication in the 4 weeks prior to study entry. Written informed consent was obtained prior to study entry and subjects were admitted as inpatients to the Emory University General Clinical Research Center. This study was conducted as part of a larger study.

2.2. Psychosocial stress procedure
----------------------------------

A standardized and validated psychosocial stress test, the Trier Social Stress Test (TSST) ([@bib14]), was performed between 15:00 h and 16:00 h. The test consists of a 10-min anticipation and preparation phase and a subsequent 10-min public speaking and mental arithmetic task in front of three individuals.

2.3. Assessments during the stress procedure
--------------------------------------------

### 2.3.1. Psychometric measures

We measured positive and negative affect before and after TSST using the Positive and Negative Affect Scale (PANAS) ([@bib8]), which comprises 20 items describing emotions experienced at the present moment.

### 2.3.2. Biological measures

At 12:00 h, an intravenous (IV) catheter was inserted and subjects were not allowed to intake anything per oral except for water until 17:00 h. Blood was sampled in ethylenediaminetetraacetic acid (EDTA) tubes through the IV before (−15 and 0 min), during (15 min) and after the stress exposure (30, 45, 60, 75, and 90 min) for assessment of plasma adrenocorticotropin (ACTH), cortisol, norepinephrine/epinephrine, and interleukin (IL)-6 concentrations. ACTH and cortisol concentrations were measured using commercial radioimmunoassays (ACTH: Nichols Institute, San Juan Capistrano, CA; cortisol: DiaSorin Corporation, Stillwater, MN). Inter- and intra-assay coefficients of variation were less than 6% for ACTH and less than 4% for cortisol. Catecholamines were measured by reverse-phase, ion pair high performance liquid chromatography. For norepinephrine, mean intra-assay coefficient of variation was 7.1% (\>800 pg/ml) and mean inter-assay coefficient of variation was 10.3% (300--550 pg/ml). For epinephrine, mean intra-assay coefficient of variation was 9.6% (\>80 pg/ml) and mean inter-assay coefficient of variation was 16.3% (60--140 pg/ml). Plasma IL-6 concentrations were measured by enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN).

### 2.3.3. Gene expression profiling

Whole blood was drawn (at 0, 30, and 60 min) into an 8 ml BD Vacutainer Cell Preparation Tube with sodium citrate (Becton Dickinson, NJ), and immediately processed according to manufacturer\'s instructions. Total ribonucleic acid (RNA) was isolated using TRIzol™ reagent (Invitrogen, CA) and RNA quality and quantity was assessed using the Agilent 2100 Bioanalyzer, all RNA used had RIN \>8.5. Contaminating deoxyribonucleic acid (DNA) was removed by incubation with 1 U DNaseI (GeneHunter Corp., TN) at 37 °C for 15 min. RNA was labeled and arrays processed as previously described ([@bib20], [@bib30]). Hybridization was onto a 20K array (MWG Biotech, Germany, now Ocimum Biosolutions). A median background value was calculated around each of the features and subtracted from the mean feature signal to give the net signal for the respective gene. The data was quantile normalized and log~2~ transformed. Features showing minimal variation across the set of arrays were excluded from the analysis, those whose expression differed by at least 1.5-fold from the median in at least 50% of the arrays were retained, giving 7247 genes for further analysis.

2.4. Statistical analyses
-------------------------

### 2.4.1. Gene set expression comparison (GSEC) analysis

The GSEC tool ([@bib32]) in BRB-ArrayTools (v3.7; <http://linus.nci.nih.gov/BRB-ArrayTools.html>) analyzes pre-defined gene sets for differential expression among pre-defined classes ([@bib21]). Gene sets for this analysis were derived from 593 BioCarta (http://www.biocarta.com), or 181 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways (http://www.genome.jp/kegg/pathway.html) and 65 experimentally verified transcription factor targets. We identified pathways whose expression was differentially regulated among the classes. By analyzing gene sets, rather than individual genes, we were able to reduce the number of tests conducted, and allow findings among biologically related genes to reinforce each other. This analysis is different than annotating a gene list using gene ontology (GO) categories. For each gene set we computed the number of genes represented on the microarray in that group, and calculated the statistical significance for each gene by a univariate analysis using a paired *t*-test with a random variance model ([@bib31]). Then, for each gene set two *p*-value summary statistics (the Fisher (LS) and the Kolmogorov--Smirnov (KS) statistics ([@bib29]) and the Efron--Tishirani\'s maxmean test statistic ([@bib9]) were calculated. The significance level associated with the gene set is the proportion of the random samples giving as large a value of the summary statistic as in the actual genes of the specified gene set. We considered a gene set to be significantly differentially regulated if one of the tests was \<0.05.

### 2.4.2. Transcription factor analysis

In an attempt to determine the over-representation of transcription factor binding sites (TFBS) within the set of co-expressed genes from the GSEC pathway analysis, as compared with a background set of genes, the Opossum system was used for enrichment analysis ([@bib12], [@bib13]). The analysis parameters looked at promoters 2000 nucleotides upstream of each gene\'s transcription start site, using a conservation level of top 10 percentile of non-coding conserved regions with an absolute minimum percent identity of 70%. Two measures of statistical over-representation were measured, a *Z*-score and a one-tailed Fisher exact probability.

### 2.4.3. Peripheral markers analysis

The Friedman test was used to compare observations repeated on the same subjects.

2.5. Microarray validation
--------------------------

### 2.5.1. Quantitative real-time polymerase chain reaction (qPCR)

Validation of the microarray gene expression findings was performed using qPCR on four genes that showed different expression patterns between the three time points for all donors. The candidate genes for validation are given in [Table 1](#tbl1){ref-type="table"} .Table 1Hydrolysis primer and probe sets used for the validation of gene expression data. The probes were labeled with the HEX fluorophore 5′, and the non-fluorescent Black Hole Quencher 3′.Gene symbolForward primer sequence (5′--3′)Reverse primer sequence (5′--3′)Probe sequence (5′--3′)Amplicon length (bp)PCR efficiency[a](#tbl1fn1){ref-type="table-fn"}GAPDHAACCTGCCAAATATGATGACATCAGCCCAGGATGCCCTTGAAGCAGGCGTCGGAGGGCCC671.88PGK1CAAGAAGTATGCTGAGGCTGTCACAAATACCCCCACAGGACCATTCGGGCTAAGCAGATTGTGTGG681.93PKCTGACAAACCCCCGTTCTTGAGTTGACATATTCCATGACGAAGTACAACTCCTGCTTCCAGACAGTGGATCGG821.80CASP8CCTGGGTGCGTCCACTTTCAAGGTTCAAGTGACCAACTCAAGTGGGCACGTGAGGTTGGGCC781.96ALDH3A2GCAGCGATTTGACCACATTTTCTAACATGGACTTTTCCCTCCCACGGTTGGCAAAATTGTCATGGAAGCT1201.88IL6RGTACCACTGCCCACATTCCTCAGCTTCCACGTCTTCTTGACCTGGCCTTCGGAACGCTCCTC711.99[^2]

Endogenous control genes were selected on the basis of the microarray gene expression data from all time points. Ten genes were selected that showed low coefficients of variation, and genes with different functions were chosen to avoid genes belonging to the same biological pathways that might be co-regulated. GeNorm was used to select the most stable pair-wise combination of reference genes: phosphoglycerate kinase 1 (PGK1) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ([Table 1](#tbl1){ref-type="table"}). The slope of a five-step fivefold dilution standard curve (100 μg--10 pg) for each primer set was used to determine their PCR amplification efficiency (10^−1/slope^). The template cDNA was pooled total RNA extracted from PBMC of several donors.

One microgram of DNAse digested RNA was reverse transcribed into cDNA using random hexamers and the Transcriptor Reverse Transcriptase kit (Roche Applied Sciences, Indianapolis, IN) according to the manufacturer\'s instructions. Quantitative real-time PCR was performed using the LightCycler^®^ 480 system and the Probes Master Mix kit (Roche) in 96 well plates according to the manufacturer\'s instructions. The primers and probes used are outlined in [Table 1](#tbl1){ref-type="table"}. All samples including the external standards and non-template control were run in duplicate. The cycling conditions consisted of one cycle at 95 °C for 5 min followed by 45 cycles of 95 °C × 15 s, 60 °C × 15 s and 72 °C × 45 s. The Lightcycler 480 software was used to extract crossing points. The data was normalized to GAPDH and PGK1 using the geometric means of the reference genes.

3. Results
==========

Demographic characteristics of the participants are summarized in [Table 2](#tbl2){ref-type="table"} . Positive affect did not change before and after stress. However, negative affect increased significantly from pre- to post-stress.Table 2Demographic features and psychological measures during psychosocial stress test.*n* = 10Mean age in years (range)32.4 (20--54)Mean BMI (range)25.8 (21.3--33.4)  Race (%) Caucasian5 (50) African-American5 (50)  PANAS-positive Pre-stress (95% CI)18.8 (12.5--25.0) Post-stress (95% CI)16.8 (9.5--24.0)  PANAS-negative Pre-stress (95% CI)3.2 (−0.8 to 7.2) Post-stress (95% CI)10.8[\*](#tbl2fn1){ref-type="table-fn"} (5.9--15.6)[^3][^4]

Analysis of repeated measures of peripheral markers revealed significant differences between time points for ACTH (*χ* ^2^(7) = 24.8; *p*  = 0.001), cortisol (*χ* ^2^(7) = 34.5; *p*  \< 0.001), norepinephrine (*χ* ^2^(7) = 47.7; *p*  \< 0.001), and epinephrine (*χ* ^2^(7) = 41.0; *p*  \< 0.001) ([Fig. 1](#fig1){ref-type="fig"}A--D). Plasma IL-6 (*χ* ^2^(7) = 38.2; *p*  \< 0.001) and log~2~ normalized signal intensity for IL-6 extracted from gene expression data are presented in [Fig. 2](#fig2){ref-type="fig"} .Fig. 1Biological measures during psychosocial stress test. Plasma ACTH (A), plasma cortisol (B), plasma norepinephrine (C), and plasma epinephrine (D) changed significantly over time. Red arrows indicate when blood sample was analyzed for PBMC gene expression. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)Fig. 2Plasma IL-6 and log2 normalized signal intensity for IL-6 extracted from gene expression data. Similar profiles for the two measures add validity to the gene expression data. Red arrows indicate when blood sample was analyzed for PBMC gene expression. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)

Comparison between baseline (0 min) and stress samples (30 min) revealed a total of 49 pathways that significantly changed (*p*  \< 0.05) ([Table 3](#tbl3){ref-type="table"} ). When comparing stress (30 min) and recovery samples (60 min), 36 pathways were significantly changed ([Table 4](#tbl4){ref-type="table"} ). The parametric *p*-values and the geometric means for all genes identified in the pathways of [Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"} can be found in [Supplementary file 1](#app1){ref-type="sec"}. Eight pathways were identified as common to each of these analyses (bold highlight, [Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}) involving 210 unique genes. This represents 36 and 45% of the unique genes common to these eight pathways. We are able to dissect out the gene expression changes in each of the pathways ([Supplementary file 2](#app1){ref-type="sec"}). The Janus kinase-signal (JAK/STAT) signaling pathway is central to the stress response and looking at the expression changes between baseline and stressor (0 and 30 min) we find 42/56 genes are showing ≥2-fold increase in expression. Then 31/42 of these genes are down-regulated (≥2-fold change) during the recovery (30--60 min). A further 11 genes in this pathway, unchanged from baseline to stress, are also down-regulated during the recovery. Similar analytical dissection of the gene regulation for the remaining seven common pathways is given in [Supplementary file 2](#app1){ref-type="sec"}.Table 3Results of the paired class comparison analysis between baseline and stress time points using BioCarta and KEGG pathways as defined gene sets. Pathways containing more than five genes present on the array were included in the analysis. This meant that 176 BioCarta and 146 KEGG pathways were considered. A univariate analysis using paired *t*-tests with a random variance model was run to determine the differentially expressed genes in each gene set. Significant gene sets were then identified with summary statistics (the LS/KS permutation test and Efron--Tishirani\'s maxmean test ([@bib9]) using a threshold of 0.05 for at least one test. In the combined BioCarta/KEGG analysis 49 pathways passed this threshold. Pathways in highlighted in bold are common to both the baseline-stress and stress--recovery analyses. *p*-Values and Log ratios are presented in [Supplementary file 1](#app1){ref-type="sec"}.Pathway IDPathway descriptionNo. of genesBiological function1h_ucalpainuCalpain and friends in Cell spread11Adhesion2h_agrAgrin in postsynaptic differentiation19Adhesion, cell migration3h_ecmErk and PI-3 kinase are necessary for collagen binding in corneal epithelia10Adhesion, cell migration4h_rhoRho cell motility signaling pathway13Adhesion, cell morphology5h_rac1Rac 1 cell motility signaling pathway10Adhesion, cell signaling6**hsa05040Huntington\'s disease13Apoptosis**7h_rasRas signaling pathway8Apoptosis8h_intrinsicIntrinsic prothrombin activation pathway6Blood collection9hsa04110Cell cycle43Cell cycle10h_g1Cell cycle: G1/S check point9Cell cycle11**h_skp2e2fE2F1 destruction pathway5Cell cycle**12h_RacCycDInfluence of Ras and Rho proteins on G1 to S Transition12Cell cycle13**h_p27Regulation of p27 phosphorylation during cell cycle progression7Cell cycle progression**14hsa04120Ubiquitin mediated proteolysis15Cell cycle, immune response15h_pmlRegulation of transcriptional activity by PML15Cell growth, apoptosis16h_At1rAngiotensin II mediated activation of JNK Pathway via Pyk216Cell migration17h_mrpMulti-drug resistance factors6Cell regulation18h_cardiacegfRole of EGF receptor transactivation by GPCRs in cardiac hypertrophy6Cell regulation19hsa04540Gap junction35Cell signaling20h_gpcrSignaling pathway from G-protein families10Cell signaling21h_erkErk1/Erk2 MAPK signaling pathway13Cell signaling, cell growth and differentiation22h_calcineurinEffects of calcineurin in keratinocyte differentiation5Cell signaling: Ca++23**hsa04630JAK/STAT signaling pathway56Cell signaling: cytokines, growth factors, stress**24hsa04310Wnt signaling pathway48Cell signaling: development, proliferation, mobility25h_pelp1Pelp1 modulation of estrogen receptor activity5Cell signaling: growth factor signaling26**hsa04010MAPK signaling pathway114Cell signaling: growth, inflammation, apoptosis**27h_fcer1Fc epsilon receptor I signaling in mast cells12Cell signaling: immunity, arachadonic acid metabolism28hsa04330Notch signaling pathway17Cell signaling: T-cell development29h_hesSegmentation clock8Cell signaling: WNT and Notch30hsa00790Folate biosynthesis14Cofactor biosynthesis31h_pparaMechanism of gene regulation by peroxisome proliferators via PPARa20Gene regulation32h_sppaAspirin blocks signaling pathway involved in platelet activation6Hemostasis33hsa04650Natural killer cell mediated cytotoxicity64Immune response: NK cell34**h_dcDendritic cells in regulating TH1 and TH2 development5Immune response: T-cell**35h_tcrT cell receptor signaling pathway14Immune response: T-cell36h_mef2dRole of MEF2D in T-cell apoptosis5Immune response: T-cell; apoptosis37hsa04730Long-term depression32Learning and memory38hsa04720Long-term potentiation28Learning and memory39hsa00380Tryptophan metabolism41Metabolism: Amino acid40hsa00530Aminosugars metabolism6Metabolism: carbohydrate41**hsa00053Ascorbate and aldarate metabolism9Metabolism: carbohydrate**42**hsa00190Oxidative phosphorylation43Metabolism: energy production**43hsa00770Pantothenate and CoA biosynthesis8Metabolism: fatty acid44hsa00531Glycosaminoglycan degradation10Metabolism: glucosamine45hsa00534Heparan sulfate biosynthesis7Metabolism: glucosamine46hsa00604Glycosphingolipid biosynthesis - ganglioseries9Metabolism: glycolipid47hsa00960Alkaloid biosynthesis II16Metabolism: secondary metabolites48h_prc2PRC2 complex long-term gene silencing by modification of histone tails7Regulation gene expression49h_arapADP-ribosylation factor10Vesicular traffickingTable 4Results of the paired class comparison analysis between stress and recovery time points using BioCarta and KEGG pathways as defined gene sets. Pathways containing more than five genes present on the array were included in the analysis. This meant that 176 BioCarta and 146 KEGG pathways were considered. A univariate analysis using paired *t*-tests with a random variance model was run to determine the differentially expressed genes in each gene set. Significant gene sets were then identified with summary statistics (the LS/KS permutation test and Efron--Tishirani\'s maxmean test ([@bib9]) using a threshold of 0.05 for at least one test. In the combined BioCarta/KEGG analysis 49 pathways passed this threshold. Pathways in highlighted in bold are common to both the baseline-stress and stress--recovery analyses. *p*-Values and Log ratios are presented in Appendix BSupplementary file 1.Pathway IDPathway descriptionNo. of genesBiological function1hsa04810Regulation of actin cytoskeleton89Adhesion2**hsa05040Huntington\'s disease13Apoptosis**3**h_p27Regulation of p27 phosphorylation during cell cycle progression7Cell cycle progression**4**h_skp2e2fE2F1 destruction pathway5Cell cycle progression, TF**5h_gsk3Inactivation of Gsk3 by AKT: accumulation of b-catenin in macrophages8Cell proliferation/differentiation6h_CCR3CCR3 signaling in eosinophils14Cell signaling7h_aktAKT signaling pathway5Cell signaling: cell survival8**hsa04630JAK/STAT signaling pathway56Cell signaling: cytokines, growth factors**9**hsa04010MAPK signaling pathway114Cell signaling: growth, inflammation, apoptosis**10hsa04912GnRH signaling pathway38Cell signaling: HPG axis11hsa04620Toll-like receptor signaling pathway45Cell signaling: immunity12hsa04664Fc epsilon RI signaling pathway36Cell signaling: immunity, arachadonic acid metabolism13h_il1rSignal transduction through IL1R15Immune response, cell signaling14h_tall1TACI and BCMA stimulation of B cell immune responses.7Immune response: B-cell15**h_dcDendritic cells in regulating TH1 and TH2 development5Immune response: T-cell**16hsa00460Cyanoamino acid metabolism5Metabolism: amino acid17hsa00340Histidine metabolism27Metabolism: amino acid18hsa00450Selenoamino acid metabolism12Metabolism: amino acid19hsa00220Urea cycle and metabolism of amino groups8Metabolism: amino acid20**hsa00053Ascorbate and aldarate metabolism9Metabolism: carbohydrate**21hsa00051Fructose and mannose metabolism17Metabolism: carbohydrate22hsa00010Glycolysis/gluconeogenesis18Metabolism: carbohydrate23hsa00030Pentose phosphate pathway6Metabolism: carbohydrate24**hsa00190Oxidative phosphorylation43Metabolism: energy**25hsa00591Linoleic acid metabolism17Metabolism: fatty acid26hsa00600Sphingolipid metabolism14Metabolism: fatty acid27h_eicosanoidEicosanoid metabolism5Metabolism: fatty acid. Stress response28hsa00940Stilbene, coumarine and lignin biosynthesis7Metabolism: xenobiotic29h_eponfkbErythropoietin mediated neuroprotection through NF-κB7NF-κB30h_hcmvHuman cytomegalovirus and Map kinase pathways8NF-κB31h_nthiNF-κB activation by non-typeable hemophilus influenzae18NF-κB32h_arenrf2Oxidative stress induced gene expression via Nrf29Stress response33hsa03020RNA polymerase10Transcription34h_eif4Regulation of eIF4e and p70 S6 kinase14Translation regulation35hsa04130SNARE interactions in vesicular transport13Vesicular trafficking36h_SARSSARS coronavirus protease8Glycolysis

The transcription factors that regulate the genes in the pathways that were found to be differentially expressed were examined by over-representation analysis ([Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"} ).Table 5Statistically over-represented TFBS in genes associated with the GSEC baseline and stress analysis as determined by Opossum. Results displayed where *Z*-score ≥5 and Fisher ≤0.01.Transcription factorTF classInformation content[a](#tbl5fn1){ref-type="table-fn"}Target gene hitsBackground TFBS rate[b](#tbl5fn2){ref-type="table-fn"}Target TFBS rate[b](#tbl5fn2){ref-type="table-fn"}*Z*-score[c](#tbl5fn3){ref-type="table-fn"}Fisher score[d](#tbl5fn4){ref-type="table-fn"}MZF1_5-13Zn-Finger, C2H29.43010.02220.024510.62.71E−07MZF1_1-4Zn-Finger, C2H28.63770.04640.049410.32.20E−04SP1Zn-Finger, C2H29.72900.020.0229.96.78E−08TEAD1TEA15.71000.00290.00379.92.07E−04RELAREL14.81410.00390.00489.22.39E−05GABPAETS13.91570.00490.00578.38.50E−05RELREL10.52270.00890.018.14.86E−07CEBPAbZIP9.22100.01180.0137.85.60E−04ELF5ETS8.73530.02910.03076.64.05E−07Spz1bHLH-ZIP11.91660.00490.00566.61.13E−08NR3C1Nuclear Receptor14.7600.00230.00276.41.48E−03ELK1ETS8.83150.02010.02136.12.56E−07HLFbZIP11.11240.00480.00545.96.55E−03Arnt-AhrbHLH9.53190.01790.01895.76.97E−05GFIZn-Finger, C2H29.52700.01690.01795.44.65E−05RORA_1Nuclear Receptor13.21970.0060.00655.01.61E−09NF-κBREL13.31800.00570.00625.05.24E−07[^5][^6][^7][^8]Table 6Statistically over-represented TFBS in genes associated with the GSEC stress and recovery analysis as determined by Opossum. Results displayed where *Z*-score ≥5 and Fisher ≤0.01.Transcription factorTF classIC[a](#tbl6fn1){ref-type="table-fn"}Target gene hitsBackground TFBS rate[b](#tbl6fn2){ref-type="table-fn"}Target TFBS rate[b](#tbl6fn2){ref-type="table-fn"}*Z*-score[c](#tbl6fn3){ref-type="table-fn"}Fisher score[d](#tbl6fn4){ref-type="table-fn"}RESTZn-Finger, C2H222.958100.00020.000617.81.72E−03NR3C1Nuclear Receptor14.749490.00230.00319.92.77E−03RELAREL14.7571050.00390.00477.13.93E−03NF-κBREL13.3451420.00570.00656.22.39E−05Spz1bHLH-ZIP11.9071270.00490.00565.89.30E−06SRFMADS17.965170.00050.00075.64.41E−02ELF5ETS8.6932800.02910.03055.24.47E−05[^9][^10][^11][^12]

The limited amount of RNA on several subjects allowed for validation of four genes by qPCR ([Fig. 3](#fig3){ref-type="fig"} ). Overall there was very good agreement of the qPCR data with the mRNA generated microarray data, in that the trends of differential expression were maintained in both.Fig. 3Comparison of microarray gene expression (left) and qPCR data (right) for selected genes. Bar chart represents averaged signal ± SD.

4. Discussion
=============

Acute stressors trigger adaptive up-regulation of natural immunity, redistribution of cells ([@bib11]), and preparation of the natural immune system ([@bib18]). In our analysis these effects from psychosocial stress are reflected in changes in acute inflammatory response pathways (see [Table 3](#tbl3){ref-type="table"}, 33--36), and pathways regulating adhesion molecules ([Table 3](#tbl3){ref-type="table"}, 1--5). The effects of the leukocytosis are more apparent in the baseline-stress analysis than the stress--recovery time period, as a greater number of pathways are associated with cell migration and adhesion in the former compared to the latter. In addition, stress response pathways associated with nuclear factor kappa B (NF-κB) appear to be associated with the stress--recovery period ([Table 4](#tbl4){ref-type="table"}, 29--32). A variety of pathways were significantly changed between baseline and stress, involving basic cell regulatory and signaling processes, many involving cell growth, differentiation and proliferation ([Table 3](#tbl3){ref-type="table"}, 17--29). Also, it was noted that ras-related C3 botulinum toxin substrate 1 (RAC1) was central to the functioning of several pathways in the baseline--stress analysis ([Table 3](#tbl3){ref-type="table"}, 1, 2 and 16). This protein is a pleiotropic regulator of many cellular processes, including the cell cycle, cell--cell adhesion, and motility (through the actin network). Thus, all these pathways are implicated in the adhesion and diapedesis of immune cells from the lymphatic system to the blood stream. A shortfall in this pilot study was that we did not monitor the cell subsets during the course of the time series, which is essential for larger scale studies, so we can account for the differences in the gene expression profiles being driven by the changes in T cell, B cell and natural killer cell populations.

Acute stressors trigger suppression of specific immunity ([@bib26]). The role of psychological stress in the regulation of lymphocyte adhesion molecules has been well examined ([@bib19], [@bib22]). These mechanisms are also reflected by changes in the pathway implicated in adhesion ([Table 3](#tbl3){ref-type="table"}, 1--5). More specifically, stress induces changes in effector T cell distribution, as can be seen by changes in the pathways involved in T helper cell mobilization ([Table 3](#tbl3){ref-type="table"}, 28 and 34--35).

Apoptosis plays an important role in the organism\'s response to acute stress. While lymphocytes expand and proliferate in response to acute stress, apoptosis has to be inhibited in the early phase of the stress response. In the later stages, though, apoptosis must occur to reduce the number of accumulated cells and to restore homeostasis. Our findings show that during stress gene products involved in apoptotic processes are altered upon exposition of the organism to acute stress ([Table 3](#tbl3){ref-type="table"}, 6--7, 15 and 23).

Several pathways involved in the immediate stress response were common across stress and recovery, indicating common mechanisms underlying the processes that allow the body to mount an adequate response and recover from a stressor to regain homeostasis. Two of the pathways, involved in metabolic processes (Oxidative Phosphorylation and Ascorbate metabolism, a total of 52 genes) all showed up-regulation of gene expression between baseline-stress, followed by down-regulation during recovery, as did the vast majority of genes in the JAK/STAT signaling pathway. The immediate physiological consequences of the stress response are evident in the analyses seen here, i.e. immune activation and energy mobilization. However, genes in the three pathways associated with the cell cycle, cell differentiation, etc., showed mixed regulation of the genes, and genes that were up- (or down-) regulated in the baseline-stress analysis were still up-regulated in the stress--recovery analysis ([Supplementary file 2](#app1){ref-type="sec"}). Some of this reflects the biological changes occurring in the lymphocyte populations with respect to cell differentiation, activation and survival, as the proportion and numbers of circulating cells changes, as is well documented during stressors ([@bib26], [@bib33]).

There are five transcription factors that are common to the genes in both GSEC pathway analyses ([Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}). These are NF-κB, V-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) (RELA), nuclear receptor subfamily 3, group C, member 1 (NR3C1 or glucocorticoid receptor), spermatogenic leucine zipper 1 (SPZ1), and E74-like factor 5 (ELF5). The first two interact with each other to form the NF-κB transcription complex. This complex is involved in cellular responses to stimuli such as stress and plays a key role in regulating the immune response ([@bib2], [@bib3]). In fact, it has recently been identified as a potential critical bridge between stress and cellular activation ([@bib4], [@bib24]). Another common transcription factor regulating the differentially expressed genes in the common pathways was NR3C1, a transcription factor that binds to glucocorticoid response elements (GRE) and is a modulator of other transcription factors. It affects inflammatory responses, cellular proliferation and differentiation. SPZ1 is involved in regulating genes involved in cell growth and differentiation, while ELF5 is an ETS-domain transcription factor, which regulate a diverse range of biological functions including mammalian hematopoiesis ([@bib28]).

Cortisol activation of the glucocorticoid receptor (GR) exerts broad anti-inflammatory effects by inhibiting NF-κB/Rel transcription factors and other pro-inflammatory signaling pathways such as the JAK/STAT signaling pathway ([@bib7], [@bib23]). Exploring the JAK/STAT signaling pathway in the baseline-stress GSEC analysis ([Supplementary file 3](#app1){ref-type="sec"}) we see 19 genes are identified with the NF-κB/RELA TFBS combination and eight genes are up-regulated ≥2-fold between baseline and stress, while only three of these genes are down-regulated. Three of five genes with NR3C1 (GR) promoter sequences in the JAK/STAT pathway are down-regulated ([Supplementary file 3](#app1){ref-type="sec"}). We find that the cortisol effects are evident in the gene expression patterns during the time series analysis. This indicates by using state-of-the-art methodologies we can explore the biological changes of psychological stressors.

When blood is collected, the intrinsic pathway is activated by contact with the collection devices causing damage to the platelets and activation of factor XII ([@bib25]). This pathway was identified as having differentially expressed genes in the baseline-stress analysis ([Table 3](#tbl3){ref-type="table"}).

Several limitations of the current study need to be addressed. The small sample size limits generalization to a broader population. Also, not all genes measured in the microarrays were annotated and genes that might be critical for the stress response might thus have been omitted from our analysis. Related to this issue, only a fraction of the annotated genes are summarized in a pathway. To some extent, we were able to address some of these limitations by analyzing gene sets, rather than individual genes, thus we were able to reduce the number of tests conducted, and allow findings among biologically related genes to reinforce each other. This functional class scoring is a more powerful method of identifying differentially expressed gene classes than the commonly used over-representation analysis, or annotation of gene lists based on individually analyzed genes ([@bib29]). It indicates which gene sets contain more differentially expressed genes than would be expected by chance. Further, we were able to measure gene expression patterns at three time points (immediately before and after, as well as 30 min after an acute stressor) in our current study. It would have certainly been of great interest to have further measures beyond that time frame. Longer lasting changes in the endocrine, immune, and sympathetic nervous system could not be captured in our study. Clearly, future studies need to incorporate more measurement time points in order to be able to capture the complex biological processes that occur following an acute stressor. Also, increasing both sample size and sampling time points will allow us to more closely describe cellular events in a chronological order as they occur before, during, and after a stressor. Finally, we chose to use a within-subject measurement approach. This allowed us to examine changes of biological pathways after exposure to an acute stressor. However, further studies that will expand our current efforts will benefit from including a control condition in which no stress intervention occurred. This will allow discerning baseline and stress-related processes.

In conclusion, we were able to show even in a small sample of healthy volunteers that effects of acute psychological stress are reflected in genome-wide transcriptional activity changes in peripheral blood. Specific pathways may be changed in specific disorders in response to psychosocial stress. Our pilot study needs to be replicated and future studies will expand our current findings by including more subjects. The stress-related changes that we were able to describe are most likely adaptive responses to a moderate stressor. It might be of great interest to use this approach in clinical samples. Identification of gene expression patterns relevant for psychiatric and somatic disorders that are related to stress has the potential to identify novel targets for the prevention and treatment of adverse outcomes of stress.
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Appendix A. Supplementary data {#app1}
==============================

Supplementary file 1Pathways identified in time series paired analysis as being differentially expressed from both the KEGG and BioCarta databases. Data includes filtered gene set associated with pathway, parametric *p*-value of each gene and geometric mean (or fold change). Gene symbols used in these tables are those designated by the HUGO Gene Nomenclature Committee (HGNC). More information on each can be obtained by searching their website: <http://www.genenames.org/>. Supplementary file 2Eight pathways identified as common to BS and SR GSEC analysis giving geometric mean intensity values (or fold change information) for each of the genes associated with these pathways. Gene symbols used in these tables are those designated by the HUGO Gene Nomenclature Committee (HGNC). More information on each can be obtained by searching their website: <http://www.genenames.org/>. Supplementary file 3Genes identified in the BS and SR GSEC analyses that are regulated by NF-κB/RELA or Glucocorticoid receptor (NR3C1) transcription factors giving geometric mean intensity values (or fold change information) for each of the genes associated with each transcription factor binding site. Gene symbols used in these tables are those designated by the HUGO Gene Nomenclature Committee (HGNC). More information on each can be obtained by searching their website: <http://www.genenames.org/>.
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[^1]: Current address: The CFIDS Association of America, PO Box 220398, Charlotte, NC 28222, USA.

[^2]: The maximum efficiency for a PCR reaction = 2.

[^3]: BMI = body mass index; PANAS = Positive Affect Negative Affect Scale.

[^4]: *p* \< 0.01.

[^5]: This is the specificity of the TFBS profile\'s position weight matrix.

[^6]: The number of times this TFBS was detected within the conserved non-coding regions of the background or target set of genes.

[^7]: The likelihood that the number of TFBS nucleotides detected for the included target genes is significant as compared with the number of TFBS nucleotides detected for the background set. *Z*-score is expressed in units of magnitude of the standard deviation.

[^8]: The probability that the number of hits vs. non-hits for the included target genes could have occurred by random chance based on the hits vs. non-hits for the background set.

[^9]: This is the specificity of the TFBS profile\'s position weight matrix.

[^10]: The number of times this TFBS was detected within the conserved non-coding regions of the background or target set of genes.

[^11]: The likelihood that the number of TFBS nucleotides detected for the included target genes is significant as compared with the number of TFBS nucleotides detected for the background set. *Z*-score is expressed in units of magnitude of the standard deviation.

[^12]: The probability that the number of hits vs. non-hits for the included target genes could have occurred by random chance based on the hits vs. non-hits for the background set.
